About
AI software support tool for detecting vascular pathology in the retina. Today, the interpretation of Fluorescein Angiography still requires ophthalmologists to manually inspect the many images generated in each test. This is time-consuming, subjective, and relies on the limited human eye. RETICAD addresses this technological gap to facilitate reliable identification of patients who can benefit from therapeutic interventions that can limit the development of vision loss.